Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CIGNA Corporation    CI

Delayed Quote. Delayed  - 02/22 10:00:33 pm
147.49 USD   +0.35%
02/22 CIGNA : Winnebago Industries Appoints John Murabito to Its Board of ..
02/22 CIGNA : Declares Annual Dividend
02/21 CIGNA : DermACELL receives coverage from Cigna
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

CIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With Anthem

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/16/2017 | 03:32pm CET
By Brent Kendall 

A Delaware judge on Wednesday issued a temporary restraining order that blocks Cigna Corp. from immediately terminating its troubled $48 billion merger with rival health insurer Anthem Inc.

The development is the latest in what could be a long and bitter legal battle between the two companies in the wake of a federal judge's ruling earlier this month that the proposed merger violates U.S. antitrust law.

Cigna on Tuesday declared it was done with the merger and sued Anthem, seeking a $1.85 billion breakup fee plus more than $13 billion in damages from its deal partner. Anthem then responded with its own lawsuit and sought an immediate order stopping Cigna from ending their pact.

Anthem obtained such an order Wednesday from Vice Chancellor J. Travis Laster, a judge on the Delaware Chancery Court, according to a Thursday filing by Cigna with the Securities and Exchange Commission.

Under the terms of the merger agreement, Anthem could extend the deal until the end of April. The firm is making a long-shot bid to win a quick appeal of U.S. District Judge Amy Berman Jackson's ruling that the merger would unlawfully harm consumers and competition.

Both Anthem and Cigna have accused one another of violating their 2015 merger deal. Cigna said Anthem's alleged violations meant it couldn't extend the merger agreement until April. Anthem said Cigna has been engaged in a campaign to sink the deal.

Cigna in a statement said, "This is not a decision on the merits of the case, but rather a procedural order to ensure irrevocable actions do not take place before the court's substantive review of the issues. Cigna respects the court's decision and will continue to abide by terms of the merger agreement until the court further reviews the case."

The insurer said another hearing will be scheduled the week of April 10.

Anthem didn't respond to a request for comment on the restraining order.

Write to Brent Kendall at brent.kendall@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CIGNA CORPORATION
02/22 CIGNA : Winnebago Industries Appoints John Murabito to Its Board of Directors
02/22 CIGNA : Declares Annual Dividend
02/21 CIGNA : DermACELL receives coverage from Cigna
02/16 CIGNA : and Fresenius Medical Care North America Collaborate to Drive Quality an..
02/16 ANTHEM : Court Halts Cigna Lawsuit In Anthem Dispute
02/16DJCIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With ..
02/16 CIGNA CORP : Other Events (form 8-K)
02/16DJANTHEM : Countersues After Cigna Ends Deal -- WSJ
02/16 CIGNA : Anthem moves to stop Cigna cancelling deal
02/15 CIGNA CORP : Regulation FD Disclosure (form 8-K)
More news
Sector news : Managed Healthcare - NEC
02/17DJAETNA : Doubles Dividend, Boosts Stock Buyback Plans
02/16DJCIGNA : Court Issues Temporary Order Keeping Cigna From Terminating Merger With ..
02/16DJANTHEM : Countersues After Cigna Ends Deal -- WSJ
02/15DJHUMANA : Withdrawal From Health Exchanges Pressures GOP -- Update
02/15DJHUMANA : Decision to Pull Out of Health Exchanges Pressures Republicans
More sector news : Managed Healthcare - NEC
News from SeekingAlpha
02/22 CIGNA declares $0.04 dividend
02/21 Cigna to cover Dermacell dermal matrix; exclusive distributor Novadaq up 9% a..
02/19 Tracking David Einhorn's Portfolio - Q4 2016 Update
02/16 Icahn Boosts Herbalife Bet While Advising Trump
02/15 Trump administration proposes changes to ACA to reduce sign-ups by sick peopl..
Advertisement
Financials ($)
Sales 2017 40 445 M
EBIT 2017 3 393 M
Net income 2017 2 345 M
Finance 2017 98,0 M
Yield 2017 0,02%
P/E ratio 2017 16,14
P/E ratio 2018 13,98
EV / Sales 2017 0,93x
EV / Sales 2018 0,87x
Capitalization 37 733 M
More Financials
Chart CIGNA CORPORATION
Duration : Period :
CIGNA Corporation Technical Analysis Chart | CI | US1255091092 | 4-Traders
Full-screen chart
Technical analysis trends CIGNA CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 165 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David Michael Cordani President, Chief Executive Officer & Director
Isaiah Harris Chairman
Mark Marsters Senior Vice President-Group Operations
Thomas A. McCarthy Chief Financial Officer & Executive Vice President
Alan M. Muney Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CIGNA CORPORATION10.18%37 733
UNITEDHEALTH GROUP INC0.33%152 729
AETNA INC1.88%44 333
ANTHEM INC14.22%43 261
HUMANA INC0.64%30 662
CENTENE CORP24.37%12 082
More Results